Daiichi Sankyo Limited (DSKYF)
PNK: DSKYF
· Real-Time Price · USD
26.63
2.47 (10.22%)
At close: May 01, 2025, 3:20 PM
10.22% (1D)
| Bid | 24.16 |
| Market Cap | 49.7B |
| Revenue (ttm) | 1,687B |
| Net Income (ttm) | 229.1B |
| EPS (ttm) | 1.08 |
| PE Ratio (ttm) | 24.65 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 26.15 |
| Volume | 9,254 |
| Avg. Volume (20D) | 72,847 |
| Open | 24.16 |
| Previous Close | 24.16 |
| Day's Range | 23.46 - 27.10 |
| 52-Week Range | 20.15 - 44.64 |
| Beta | 0.33 |
About DSKYF
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders;...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jun 24, 2008
Employees 18,726
Stock Exchange PNK
Ticker Symbol DSKYF
Website https://www.daiichisankyo.com
